PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.

Progress Toward Measles Elimination - African Region, 2013-2016.

Abstract In 2011, the 46 World Health Organization (WHO) African Region (AFR) member states established a goal of measles elimination* by 2020, by achieving 1) ≥95% coverage of their target populations with the first dose of measles-containing vaccine (MCV1) at national and district levels; 2) ≥95% coverage with measles-containing vaccine (MCV) per district during supplemental immunization activities (SIAs); and 3) confirmed measles incidence of <1 case per 1 million population in all countries (1). Two key surveillance performance indicator targets include 1) investigating ≥2 cases of nonmeasles febrile rash illness per 100,000 population annually, and 2) obtaining a blood specimen from ≥1 suspected measles case in ≥80% of districts annually (2). This report updates the previous report (3) and describes progress toward measles elimination in AFR during 2013-2016. Estimated regional MCV1 coverage(†) increased from 71% in 2013 to 74% in 2015.(§) Seven (15%) countries achieved ≥95% MCV1 coverage in 2015.(¶) The number of countries providing a routine second MCV dose (MCV2) increased from 11 (24%) in 2013 to 23 (49%) in 2015. Forty-one (79%) of 52 SIAs** during 2013-2016 reported ≥95% coverage. Both surveillance targets were met in 19 (40%) countries in 2016. Confirmed measles incidence in AFR decreased from 76.3 per 1 million population to 27.9 during 2013-2016. To eliminate measles by 2020, AFR countries and partners need to 1) achieve ≥95% 2-dose MCV coverage through improved immunization services, including second dose (MCV2) introduction; 2) improve SIA quality by preparing 12-15 months in advance, and using readiness, intra-SIA, and post-SIA assessment tools; 3) fully implement elimination-standard surveillance(††); 4) conduct annual district-level risk assessments; and 5) establish national committees and a regional commission for the verification of measles elimination.
PMID
Related Publications

Progress toward measles elimination--Eastern Mediterranean Region, 2008-2012.

Global control and regional elimination of measles, 2000-2011.

Progress Toward Measles Elimination - Nepal, 2007-2014.

Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010.

Progress toward measles preelimination--African Region, 2011-2012.

Authors

Mayor MeshTerms

Disease Eradication

Population Surveillance

Keywords
Journal Title mmwr. morbidity and mortality weekly report
Publication Year Start




PMID- 28472026
OWN - NLM
STAT- MEDLINE
DA  - 20170504
DCOM- 20170516
LR  - 20170516
IS  - 1545-861X (Electronic)
IS  - 0149-2195 (Linking)
VI  - 66
IP  - 17
DP  - 2017 May 05
TI  - Progress Toward Measles Elimination - African Region, 2013-2016.
PG  - 436-443
LID - 10.15585/mmwr.mm6617a2 [doi]
AB  - In 2011, the 46 World Health Organization (WHO) African Region (AFR) member
      states established a goal of measles elimination* by 2020, by achieving 1) &gt;/=95%
      coverage of their target populations with the first dose of measles-containing
      vaccine (MCV1) at national and district levels; 2) &gt;/=95% coverage with
      measles-containing vaccine (MCV) per district during supplemental immunization
      activities (SIAs); and 3) confirmed measles incidence of &lt;1 case per 1 million
      population in all countries (1). Two key surveillance performance indicator
      targets include 1) investigating &gt;/=2 cases of nonmeasles febrile rash illness
      per 100,000 population annually, and 2) obtaining a blood specimen from &gt;/=1
      suspected measles case in &gt;/=80% of districts annually (2). This report updates
      the previous report (3) and describes progress toward measles elimination in AFR 
      during 2013-2016. Estimated regional MCV1 coveragedagger increased from 71% in
      2013 to 74% in 2015. section sign Seven (15%) countries achieved &gt;/=95% MCV1
      coverage in 2015. paragraph sign The number of countries providing a routine
      second MCV dose (MCV2) increased from 11 (24%) in 2013 to 23 (49%) in 2015.
      Forty-one (79%) of 52 SIAs** during 2013-2016 reported &gt;/=95% coverage. Both
      surveillance targets were met in 19 (40%) countries in 2016. Confirmed measles
      incidence in AFR decreased from 76.3 per 1 million population to 27.9 during
      2013-2016. To eliminate measles by 2020, AFR countries and partners need to 1)
      achieve &gt;/=95% 2-dose MCV coverage through improved immunization services,
      including second dose (MCV2) introduction; 2) improve SIA quality by preparing
      12-15 months in advance, and using readiness, intra-SIA, and post-SIA assessment 
      tools; 3) fully implement elimination-standard surveillancedaggerdagger; 4)
      conduct annual district-level risk assessments; and 5) establish national
      committees and a regional commission for the verification of measles elimination.
FAU - Masresha, Balcha G
AU  - Masresha BG
FAU - Dixon, Meredith G
AU  - Dixon MG
FAU - Kriss, Jennifer L
AU  - Kriss JL
FAU - Katsande, Reggis
AU  - Katsande R
FAU - Shibeshi, Messeret E
AU  - Shibeshi ME
FAU - Luce, Richard
AU  - Luce R
FAU - Fall, Amadou
AU  - Fall A
FAU - Dosseh, Annick R G A
AU  - Dosseh ARGA
FAU - Byabamazima, Charles R
AU  - Byabamazima CR
FAU - Dabbagh, Alya J
AU  - Dabbagh AJ
FAU - Goodson, James L
AU  - Goodson JL
FAU - Mihigo, Richard
AU  - Mihigo R
LA  - eng
PT  - Journal Article
DEP - 20170505
PL  - United States
TA  - MMWR Morb Mortal Wkly Rep
JT  - MMWR. Morbidity and mortality weekly report
JID - 7802429
RN  - 0 (Measles Vaccine)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Africa/epidemiology
MH  - Child
MH  - Child, Preschool
MH  - *Disease Eradication
MH  - Humans
MH  - Immunization Programs
MH  - Immunization Schedule
MH  - Incidence
MH  - Infant
MH  - Measles/*epidemiology/*prevention &amp; control
MH  - Measles Vaccine/administration &amp; dosage
MH  - *Population Surveillance
MH  - Vaccination/utilization
MH  - Young Adult
EDAT- 2017/05/05 06:00
MHDA- 2017/05/17 06:00
CRDT- 2017/05/05 06:00
AID - 10.15585/mmwr.mm6617a2 [doi]
PST - epublish
SO  - MMWR Morb Mortal Wkly Rep. 2017 May 5;66(17):436-443. doi:
      10.15585/mmwr.mm6617a2.

<?xml version="1.0" encoding="UTF-8"?>
<b:Sources SelectedStyle="" xmlns:b="http://schemas.openxmlformats.org/officeDocument/2006/bibliography"  xmlns="http://schemas.openxmlformats.org/officeDocument/2006/bibliography" >
</b:Sources>